Type I interferon counters or promotes Coxiella burnetii replication dependent on tissue

Infection and Immunity

Volumn 84, Issue 6, 2016, Pages 1815-1825

  Hedges, Jodi F ^a   Robison, Amanda ^a   Kimmel, Emily ^a   Christensen, Kelly ^a   Lucas, Erin ^a   Ramstead, Andrew ^a   Jutila, Mark A ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; DOUBLE STRANDED RNA; INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; RECOMBINANT ALPHA INTERFERON; ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; APTAMER; IFNAR1 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CONTROLLED STUDY; COXIELLA BURNETII; DISEASE EXACERBATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; Q FEVER; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; LEGIONELLA PNEUMOPHILA; LUNG ALVEOLUS MACROPHAGE; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APTAMERS, NUCLEOTIDE; BRONCHOALVEOLAR LAVAGE FLUID; COXIELLA BURNETII; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INJECTIONS, INTRAPERITONEAL; INTERFERON-ALPHA; INTERLEUKIN-1BETA; LEGIONELLA PNEUMOPHILA; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; Q FEVER; RECEPTOR, INTERFERON ALPHA-BETA; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; WEIGHT LOSS;

EID: 84971520489     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01540-15     Document Type: Article

References (49)

1. O'Connell RM, Saha SK, Vaidya SA, Bruhn KW, Miranda GA, Zarnegar B, Perry AK, Nguyen BO, Lane TF, Taniguchi T, Miller JF, Cheng G. 2004. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 200: 437-445. http://dx.doi.org/10.1084/jem.20040712.
2. Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S, Catalfamo M, Salazar AM, Via LE, Barry CE III, Sher A. 2014. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511: 99-103. http://dx.doi.org/10.1038/nature13489.
3. Martin FJ, Gomez MI, Wetzel DM, Memmi G, O'Seaghdha M, Soong G, Schindler C, Prince A. 2009. Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest 119: 1931-1939.
4. Parker D, Prince A. 2011. Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol 32: 582-588. http://dx.doi.org/10.1016/j.it.2011.09.003.
5. Helbig KJ, Heatley SL, Harris RJ, Mullighan CG, Bardy PG, Marmion BP. 2003. Variation in immune response genes and chronic Q fever. Concepts: preliminary test with post-Q fever fatigue syndrome. Genes Immun 4: 82-85.
6. Dahlgren FS, Haberling DL, McQuiston JH. 2015. Q fever is underestimated in the United States: a comparison of fatal Q fever cases from two national reporting systems. Am J Trop Med Hyg 92: 244-246. http://dx.doi.org/10.4269/ajtmh.14-0502.
7. Williams KP, Gillespie JJ, Sobral BWS, Nordberg EK, Snyder EE, Shallom JM, Dickerman AW. 2010. Phylogeny of Gammaproteobacteria. J Bacteriol 192: 2305-2314. http://dx.doi.org/10.1128/JB.01480-09.
8. Schiavoni G, Mauri C, Carlei D, Belardelli F, Castellani Pastoris M, Proietti E. 2004. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-")-independent pathway. J Immunol 173: 1266-1275. http://dx.doi.org/10.4049/jimmunol.173.2.1266.
9. Opitz B, Vinzing M, van Laak V, Schmeck B, Heine G, Günther S, Preissner R, Slevogt H, N-Guessan PD, Eitel J, Goldmann T, Flieger A, Suttorp N, Hippenstiel S. 2006. Legionella pneumophila induces IFNf3 in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem 281: 36173-36179. http://dx.doi.org/10.1074/jbc.M604638200.
10. Plumlee CR, Lee C, Beg AA, Decker T, Shuman HA, Schindler C. 2009. Interferons direct an effective innate response to Legionella pneumophila infection. J Biol Chem 284: 30058-30066. http://dx.doi.org/10.1074/jbc.M109.018283.
11. Coers J, Vance RE, Fontana MF, Dietrich WF. 2007. Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol 9: 2344-2357. http://dx.doi.org/10.1111/j.1462-5822.2007.00963.x.
12. Ang DKY, Oates CVL, Schuelein R, Kelly M, Sansom FM, Bourges De, Boon L, Hertzog PJ, Hartland EL, van Driel IR. 2010. Cutting edge: pulmonary Legionella pneumophila is controlled by plasmacytoid dendritic cells but not type I IFN. J Immunol 184: 5429-5433. http://dx.doi.org/10.4049/jimmunol.1000128.
13. Lippmann J, Müller HC, Naujoks J, Tabeling C, Shin S, Witzenrath M, Hellwig K, Kirschning CJ, Taylor GA, Barchet W, Bauer S, Suttorp N, Roy CR, Opitz B. 2011. Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice. Cell Microbiol 13: 1668-1682. http://dx.doi.org/10.1111/j.1462-5822.2011.01646.x.
14. Honstettre A, Imbert G, Ghigo E, Gouriet F, Capo C, Raoult D, Mege JL. 2003. Dysregulation of cytokines in acute Q fever: role of interleukin-10 and tumor necrosis factor in chronic evolution of Q fever. J Infect Dis 187: 956-962. http://dx.doi.org/10.1086/368129.
15. Waag DM, Kende M, Damrow TA, Wood OL, Williams JC. 1990. Injection of inactivated phase I Coxiella burnetii increases non-specific resistance to infection and stimulates lymphokine production in mice. Ann N Y Acad Sci 590: 203-214. http://dx.doi.org/10.1111/j.1749-6632.1990.tb42221.x.
16. Ghigo E, Capo C, Raoult D, Mege JL. 2001. Interleukin-10 stimulates Coxiella burnetii replication in human monocytes through tumor necrosis factor down-modulation: role in microbicidal defect of Q fever. Infect Immun 69: 2345-2352. http://dx.doi.org/10.1128/IAI.69.4.2345-2352.2001.
17. Ghigo E, Honstettre Al, Capo C, Gorvel JP, Raoult D, Mege JL. 2004. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever. J Infect Dis 190: 1767-1772. http://dx.doi.org/10.1086/425041.
18. Meghari S, Bechah Y, Capo C, Lepidi H, Raoult D, Murray PJ, Mege JL. 2008. Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis. PLoS Pathog 4: e23. http://dx.doi.org/10.1371/journal.ppat.0040023.
19. Andoh M, Zhang G, Russell-Lodrigue KE, Shive HR, Weeks BR, Samuel JE. 2007. T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice. Infect Immun 75: 3245-3255. http://dx.doi.org/10.1128/IAI.01767-06.
20. Dellacasagrande J, Capo C, Raoult D, Mege JL. 1999. IFN-") mediated control of Coxiella burnetii survival in monocytes: the role of cell apoptosis and TNF. J Immunol 162: 2259-2265.
21. Capo C, Zugun F, Stein A, Tardei G, Lepidi H, Raoult D, Mege JL. 1996. Upregulation of tumor necrosis factor alpha and interleukin-1 beta in Q fever endocarditis. Infect Immun 64: 1638-1642.
22. Kole A, He J, Rivollier A, Silveira DD, Kitamura K, Maloy KJ, Kelsall BL. 2013. Type I IFNs regulate effector and regulatory T cell accumulation and anti-inflammatory cytokine production during T cell-mediated colitis. J. Immunol 191: 2771-2779. http://dx.doi.org/10.4049/jimmunol.1301093.
23. Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J. 2011. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213-223. http://dx.doi.org/10.1016/j.immuni.2011.02.006.
24. Novikov A, Cardone M, Thompson R, Shenderov K, Kirschman KD, Mayer-Barber KD, Myers TG, Rabin RL, Trinchieri G, Sher A, Feng CG. 2011. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1 production in human macrophages. J Immunol 187: 2540-2547. http://dx.doi.org/10.4049/jimmunol.1100926.
25. Zvilich M, Williams JC, Waag D, Rill WR, Malli RJ, Bell P, Kende M. 1995. Characterization of the non-specific humoral and cellular antiviral immunity stimulated by the chloroform-methanol residue (CMR) fraction of Coxiella burnetii. Antiviral Res 27: 389-404. http://dx.doi.org/10.1016/0166-3542(95)00022-E.
26. Graham JG, MacDonald LJ, Hussain SK, Sharma UM, Kurten RC, Voth DE. 2013. Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell Microbiol 15: 1012-1025. http://dx.doi.org/10.1111/cmi.12096.
27. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA, Fitzgerald KA, Sassetti CM, Kelliher MA. 2009. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 5: e1000500. http://dx.doi.org/10.1371/journal.ppat.1000500.
28. Larson CL, Beare PA, Voth DE, Howe D, Cockrell DC, Bastidas RJ, Valdivia RH, Heinzen RA. 2015. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication. Infect Immun 83: 661-670. http://dx.doi.org/10.1128/IAI.02763-14.
29. Read AJ, Erickson S, Harmsen AG. 2010. Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii. Infect Immun 78: 3019-3026. http://dx.doi.org/10.1128/IAI.00101-10.
30. Coleman SA, Fischer ER, Howe D, Mead DJ, Heinzen RA. 2004. Temporal analysis of Coxiella burnetii morphological differentiation. J Bacteriol 186: 7344-7352. http://dx.doi.org/10.1128/JB.186.21.7344-7352.2004.
31. Westphal O, Jann K. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure, p 83-91. In Whistler RL, Wolfan ML (ed), Methods in carbohydrate chemistry. Academic Press, New York, NY.
32. Raoult D, Marrie TJ, Mege JL. 2005. Natural history and pathophysiology of Q fever. Lancet Infect Dis 5: 219-226. http://dx.doi.org/10.1016/S1473-3099(05)70052-9.
33. Zou J, Kawai T, Tsuchida T, Kozaki T, Tanaka H, Shin KS, Kumar H, Akira S. 2013. Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis. Immunity 38: 717-728. http://dx.doi.org/10.1016/j.immuni.2012.12.007.
34. Shannon JG, Howe D, Heinzen RA. 2005. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc Natl Acad SciUSA 102: 8722-8727. http://dx.doi.org/10.1073/pnas.0501863102.
35. Seo SU, Kwon HJ, Ko HJ, Byun YH, Seong BL, Uematsu S, Akira S, Kweon MN. 2011. Type I interferon signaling regulates Ly6Chi monocytes and neutrophils during acute viral pneumonia in mice. PLoS Pathog 7: e1001304. http://dx.doi.org/10.1371/journal.ppat.1001304.
36. Taylor D, Wilkison M, Voyich J, Meissner N. 2011. Prevention of bone marrow cell apoptosis and regulation of hematopoiesis by type I IFNs during systemic responses to pneumocystis lung infection. J. Immunol 186: 5956-5967. http://dx.doi.org/10.4049/jimmunol.1003558.
37. Zhang L, Yuan S, Cheng G, Guo B. 2011. Type I IFN promotes IL-10 production from t cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6: e28432. http://dx.doi.org/10.1371/journal.pone.0028432.
38. Llorente L, Richaud-Patin Y, Garcia-Padilla C, Claret E, Jakez-Ocampo J, Cardiel MH, Alcocer-Varela J, Grangeot-Keros L, Alarcin-Segovia D, Wijdenes J, Galanaud P, Emilie D. 2000. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum 43: 1790-1800. http://dx.doi.org/10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2.
39. Jensen S, Gad M. 2010. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity. J Inflamm 7: 37. http://dx.doi.org/10.1186/1476-9255-7-37.
40. Ghigo E, Capo C, Tung CH, Raoult D, Gorvel JP, Mege JL. 2002. Coxiella burnetii survival in THP-1 monocytes involves the impairment of phagosome maturation: IFN") mediates its restoration and bacterial killing. J Immunol 169: 4488-4495. http://dx.doi.org/10.4049/jimmunol.169.8.4488.
41. Cunha LD, Zamboni DS. 2013. Subversion of inflammasome activation and pyroptosis by pathogenic bacteria. Front Cell Infect Microbiol 3: 76. http://dx.doi.org/10.3389/fcimb.2013.00076.
42. Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. 2013. IL-1f3 promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol 190: 4196-4204. http://dx.doi.org/10.4049/jimmunol.1202688.
43. Goritzka M, Durant LR, Pereira C, Salek-Ardakani S, Openshaw PJM, Johansson C. 2014. Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 88: 6128-6136. http://dx.doi.org/10.1128/JVI.00333-14.
44. Kolb JP, Casella CR, SenGupta S, Chilton PM, Mitchell TC. 2014. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF. Sci Signal 7: ra108. http://dx.doi.org/10.1126/scisignal.2005442.
45. Toman R, Garidel P, Andra J, Slaba K, Hussein A, Koch MH, Brandenburg K. 2004. Physicochemical characterization of the endotoxins from Coxiella burnetii strain Priscilla in relation to their bioactivities. BMC Biochem 5: 1. http://dx.doi.org/10.1186/1471-2091-5-1.
46. Hajjar AM, Ernst RK, Fortuno ES, Brasfield AS, Yam CS, Newlon LA, Kollmann TR, Miller SI, Wilson CB. 2012. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog 8: e1002963. http://dx.doi.org/10.1371/journal.ppat.1002963.
47. Sheikh F, Dickensheets H, Gamero AM, Vogel SN, Donnelly RP. 2014. An essential role for IFN-β in the induction of IFN-stimulated gene expression by LPS in macrophages. J Leukoc Biol 96: 591-600. http://dx.doi.org/10.1189/jlb.2A0414-191R.
48. Jacobs AT, Ignarro LJ. 2001. LPS-induced expression of interferon-beta mediates the timing of nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 276:47950-47957.
49. Dahlgren FS, McQuiston JH, Massung RF, Anderson AD. 2015. Q fever in the United States: summary of case reports from two national surveillance systems, 2000-2012. Am J Trop Med Hyg 92: 247-255. http://dx.doi.org/10.4269/ajtmh.14-0503.